Uncategorized
Omeros Corporation Reports Third Quarter 2018 Financial Results
SEATTLE--(BUSINESS WIRE)--Omeros Corporation (NASDAQ: OMER) today announced recent highlights and developments as well as financial results for the third quarter ended September 30, 2018, which include: 3Q 2018 total and OMIDRIA® revenues were $4.6 million, compared to $1.7 million in 2Q 2018 and $21.7 million in last year’s third quarter. The increase over the last quarter is primarily due to revenues from the company’s wholesalers in anticipation of renewed buying from ambulatory surgery cent